AON
62
8
URI
49
3
CHD
34
2
LEG
64
5
KO
39
-5
HUM
37
3
PFE
39
-12
MET
64
3
HPE
68
-7
CI
48
6
ECL
54
2
MAC
68
3
M
59
6
GOOG
59
-6
PNC
80
4
NI
62
2
STX
73
2
FOX
71
-2
BWA
61
2
NOC
51
3
AON
62
8
URI
49
3
CHD
34
2
LEG
64
5
KO
39
-5
HUM
37
3
PFE
39
-12
MET
64
3
HPE
68
-7
CI
48
6
ECL
54
2
MAC
68
3
M
59
6
GOOG
59
-6
PNC
80
4
NI
62
2
STX
73
2
FOX
71
-2
BWA
61
2
NOC
51
3
Financhill
Back

Oracle Corp. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
26

ORCL
Oracle Corp.

Last Price:
$190.06
Seasonality Move:
9.06%
Sell
33

NKTR
Nektar Therapeutics

Last Price:
$53.93
Seasonality Move:
11.58%
Sell
26
Oracle Corp. (ORCL) is a Sell

Is Oracle Corp. a Buy, Sell or Hold?

  • The current Oracle Corp. [ORCL] share price is $198.85. The Score for ORCL is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ORCL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ORCL Stock Price Chart

What is Oracle Corp.'s stock price today?

  • The Oracle Corp. share price today is $198.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORCL is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $51.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

ORCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.24 Sell
Relative Strength Index (14 RSI): 34.73 Sell
Chaikin Money Flow: 60520832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (202.65 - 230.35) Sell
Bollinger Bands (100): (221.46 - 288.74) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 39.75 Sell
Chaikin Money Flow: -893008 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.73 - 61.07) Sell
Bollinger Bands (100): (32.3 - 62.42) Buy

ORCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 213.08 Sell
20-day SMA: 211.28 Sell
50-day SMA: 249.17 Sell
200-day SMA: 212.8 Sell
8-day EMA: 212.35 Sell
20-day EMA: 217.66 Sell
50-day EMA: 235.83 Sell
200-day EMA: 222.25 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.44 Sell
20-day SMA: 58.08 Sell
50-day SMA: 58.52 Sell
200-day SMA: 30.43 Buy
8-day EMA: 56.58 Sell
20-day EMA: 57.71 Sell
50-day EMA: 55.82 Sell
200-day EMA: 37.69 Buy

Oracle Corp. Earnings Growth & ORCL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.17 per share, an increase this year of $0.41 per share, and an increase next year of $1.33 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Oracle Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):